NRC Health Operating Lease Right-of-Use Assets
NRC Health (NRC) had Operating Lease Right-of-Use Assets of $1.16 million as of 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-03-05
- 2025-12-31: Operating Lease, Right-of-Use Asset $1.16M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $1.27M.
- 2025-06-30: Operating Lease, Right-of-Use Asset $1.41M.
- 2025-03-31: Operating Lease, Right-of-Use Asset $1.50M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2025-12-31 | $1.16M 10-K · filed 2026-03-05 | |
| 2025-09-30 | $1.27M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $1.41M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $1.50M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $1.63M 10-K · filed 2026-03-05 | |
| 2024-06-30 | $1.81M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $1.94M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $2.06M 10-K · filed 2025-03-17 | |
| 2023-09-30 | $1.16M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $344.00K 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $450.00K 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $556.00K 10-K · filed 2024-02-27 | |
| 2022-09-30 | $661.00K 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $787.00K 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $914.00K 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $975.00K 10-K · filed 2023-03-03 | |
| 2021-09-30 | $1.06M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $1.13M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $1.31M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $1.31M 10-K · filed 2022-03-04 | |
| 2020-09-30 | $1.21M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $1.31M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $1.46M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $1.63M 10-K · filed 2021-03-05 | |
| 2019-09-30 | $1.80M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $1.99M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $2.14M 10-Q · filed 2019-05-08 | |
| 2019-01-01 | $2.30M 10-K · filed 2021-03-05 | $2.31M 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |